Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
104.54
+0.35 (0.34%)
Jun 10, 2026, 9:41 AM EDT - Market open
Encompass Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10,370 | 10,614 | 9,307 | 6,692 | 5,969 | 5,163 | |
Market Cap Growth | -13.26% | 14.05% | 39.07% | 12.11% | 15.61% | -21.00% |
Enterprise Value | 13,014 | 13,993 | 12,515 | 10,121 | 9,409 | 8,959 |
Last Close Price | 104.54 | 106.14 | 92.35 | 66.72 | 59.81 | 51.89 |
PE Ratio | 17.47 | 19.16 | 20.71 | 19.23 | 23.36 | 17.35 |
Forward PE | 17.10 | 18.91 | 20.09 | 18.12 | 18.95 | 14.99 |
PEG Ratio | 1.70 | 1.30 | 1.14 | 1.34 | - | 0.72 |
PS Ratio | 1.70 | 1.79 | 1.73 | 1.39 | 1.37 | 1.29 |
PB Ratio | 4.11 | 4.35 | 4.50 | 4.06 | 4.56 | 2.70 |
P/TBV Ratio | 4.22 | 4.45 | 4.57 | 4.10 | 4.58 | 2.72 |
P/FCF Ratio | 22.26 | 24.17 | 25.83 | 25.00 | 49.05 | 30.35 |
P/OCF Ratio | 8.61 | 9.03 | 9.28 | 7.87 | 8.46 | 7.21 |
EV/Sales Ratio | 2.15 | 2.36 | 2.33 | 2.11 | 2.16 | 2.23 |
EV/EBITDA Ratio | 9.14 | 10.13 | 10.75 | 10.06 | 10.77 | 10.19 |
EV/EBIT Ratio | 11.97 | 13.29 | 14.48 | 13.83 | 14.93 | 13.59 |
EV/FCF Ratio | 28.02 | 31.86 | 34.73 | 37.81 | 77.31 | 52.67 |
Debt / Equity Ratio | 0.81 | 0.81 | 0.89 | 1.26 | 1.58 | 1.43 |
Debt / EBITDA Ratio | 1.05 | 1.97 | 2.33 | 2.92 | 3.42 | 3.96 |
Debt / FCF Ratio | 6.01 | 6.18 | 7.53 | 10.96 | 24.59 | 20.47 |
Net Debt / Equity Ratio | 1.04 | 1.07 | 1.25 | 1.72 | 2.24 | 1.76 |
Net Debt / EBITDA Ratio | 0.99 | 1.89 | 2.23 | 2.81 | 3.36 | 3.83 |
Net Debt / FCF Ratio | 5.66 | 5.95 | 7.19 | 10.57 | 24.15 | 19.81 |
Asset Turnover | 1.06 | 0.87 | 0.85 | 0.82 | 0.70 | 0.60 |
Quick Ratio | 0.96 | 0.86 | 0.86 | 1.09 | 1.02 | 0.84 |
Current Ratio | 1.17 | 1.08 | 1.05 | 1.28 | 1.25 | 1.23 |
Return on Equity (ROE) | 29.99% | 24.82% | 23.29% | 22.84% | 16.46% | 18.32% |
Return on Assets (ROA) | 26.74% | 12.33% | 10.94% | 9.75% | 7.84% | 7.91% |
Return on Invested Capital (ROIC) | 30.42% | 13.82% | 12.31% | 10.96% | 8.71% | 8.94% |
Return on Capital Employed (ROCE) | 36.68% | 17.63% | 15.52% | 13.93% | 11.28% | 11.13% |
Earnings Yield | 5.88% | 5.22% | 4.83% | 5.20% | 4.28% | 5.76% |
FCF Yield | 4.49% | 4.14% | 3.87% | 4.00% | 2.04% | 3.29% |
Dividend Yield | 0.73% | 0.67% | 0.68% | 0.91% | 1.67% | 2.18% |
Payout Ratio | 12.70% | 12.56% | 13.78% | 17.16% | 36.36% | 27.10% |
Buyback Yield / Dilution | 0.34% | 0.00% | -0.89% | -0.90% | -0.20% | -0.40% |
Total Shareholder Return | 1.07% | 0.67% | -0.21% | 0.01% | 1.47% | 1.78% |